Rank | Gene Set | Z-score |
---|---|---|
1 | central nervous system myelination (GO:0022010) | 7.38342025 |
2 | axon ensheathment in central nervous system (GO:0032291) | 7.38342025 |
3 | axon ensheathment (GO:0008366) | 4.91364738 |
4 | ensheathment of neurons (GO:0007272) | 4.91364738 |
5 | myelination (GO:0042552) | 4.90629834 |
6 | fatty acid elongation (GO:0030497) | 4.64620507 |
7 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.11499329 |
8 | regulation of collateral sprouting (GO:0048670) | 3.90277743 |
9 | photoreceptor cell differentiation (GO:0046530) | 3.80875121 |
10 | eye photoreceptor cell differentiation (GO:0001754) | 3.80875121 |
11 | negative regulation of protein localization to cell surface (GO:2000009) | 3.75158634 |
12 | establishment of mitochondrion localization (GO:0051654) | 3.70191109 |
13 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.62129261 |
14 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.60064173 |
15 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 3.58412914 |
16 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 3.58412914 |
17 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.43687457 |
18 | myelin maintenance (GO:0043217) | 3.39547254 |
19 | cholesterol biosynthetic process (GO:0006695) | 3.37076114 |
20 | negative regulation of neurotransmitter transport (GO:0051589) | 3.36285100 |
21 | epithelial cilium movement (GO:0003351) | 3.35035671 |
22 | myelination in peripheral nervous system (GO:0022011) | 3.27264650 |
23 | peripheral nervous system axon ensheathment (GO:0032292) | 3.27264650 |
24 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.24773380 |
25 | postsynaptic membrane organization (GO:0001941) | 3.23047647 |
26 | substantia nigra development (GO:0021762) | 3.21704213 |
27 | response to redox state (GO:0051775) | 3.20376952 |
28 | L-amino acid import (GO:0043092) | 3.18218364 |
29 | negative regulation of axonogenesis (GO:0050771) | 3.16847355 |
30 | detection of temperature stimulus (GO:0016048) | 3.15819756 |
31 | presynaptic membrane organization (GO:0097090) | 3.10116266 |
32 | transmission of nerve impulse (GO:0019226) | 3.08078126 |
33 | intraciliary transport (GO:0042073) | 3.07878851 |
34 | cilium movement (GO:0003341) | 3.07150558 |
35 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.04457328 |
36 | neuron cell-cell adhesion (GO:0007158) | 3.04282719 |
37 | neuronal action potential propagation (GO:0019227) | 3.03821990 |
38 | neuronal ion channel clustering (GO:0045161) | 3.00335928 |
39 | sterol biosynthetic process (GO:0016126) | 3.00160303 |
40 | neuronal action potential (GO:0019228) | 2.99273996 |
41 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.98136238 |
42 | presynaptic membrane assembly (GO:0097105) | 2.97882416 |
43 | synaptic vesicle maturation (GO:0016188) | 2.95102159 |
44 | creatine metabolic process (GO:0006600) | 2.94512572 |
45 | astrocyte development (GO:0014002) | 2.94299443 |
46 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.93962989 |
47 | negative regulation of axon extension (GO:0030517) | 2.90982054 |
48 | negative regulation of axon guidance (GO:1902668) | 2.83800277 |
49 | apical protein localization (GO:0045176) | 2.83596205 |
50 | import into cell (GO:0098657) | 2.83306443 |
51 | nerve growth factor signaling pathway (GO:0038180) | 2.82433629 |
52 | oligodendrocyte differentiation (GO:0048709) | 2.81863842 |
53 | adult walking behavior (GO:0007628) | 2.80493192 |
54 | retinal cone cell development (GO:0046549) | 2.79550441 |
55 | paraxial mesoderm development (GO:0048339) | 2.77146642 |
56 | regulation of cell communication by electrical coupling (GO:0010649) | 2.77079225 |
57 | axonemal dynein complex assembly (GO:0070286) | 2.76585863 |
58 | axon extension involved in axon guidance (GO:0048846) | 2.75738651 |
59 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.75738651 |
60 | central nervous system neuron axonogenesis (GO:0021955) | 2.71125850 |
61 | asymmetric protein localization (GO:0008105) | 2.70072599 |
62 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.69291603 |
63 | cell migration in hindbrain (GO:0021535) | 2.69019482 |
64 | regulation of axon guidance (GO:1902667) | 2.68657800 |
65 | enteric nervous system development (GO:0048484) | 2.66711957 |
66 | neuron remodeling (GO:0016322) | 2.66354370 |
67 | dendrite morphogenesis (GO:0048813) | 2.64234146 |
68 | neuron recognition (GO:0008038) | 2.64057705 |
69 | limb bud formation (GO:0060174) | 2.63061396 |
70 | dendritic spine morphogenesis (GO:0060997) | 2.62866263 |
71 | response to methylmercury (GO:0051597) | 2.62395982 |
72 | artery development (GO:0060840) | 2.60913711 |
73 | protein palmitoylation (GO:0018345) | 2.60875546 |
74 | cellular response to epinephrine stimulus (GO:0071872) | 2.60455069 |
75 | isoprenoid biosynthetic process (GO:0008299) | 2.59928423 |
76 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.58880514 |
77 | limb development (GO:0060173) | 2.58771654 |
78 | appendage development (GO:0048736) | 2.58771654 |
79 | lateral sprouting from an epithelium (GO:0060601) | 2.58765189 |
80 | nonmotile primary cilium assembly (GO:0035058) | 2.58413249 |
81 | glycerophospholipid catabolic process (GO:0046475) | 2.58138947 |
82 | neurofilament cytoskeleton organization (GO:0060052) | 2.57431164 |
83 | positive regulation of action potential (GO:0045760) | 2.54319403 |
84 | retinal ganglion cell axon guidance (GO:0031290) | 2.53528885 |
85 | cilium morphogenesis (GO:0060271) | 2.53077380 |
86 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.52882069 |
87 | peripheral nervous system neuron development (GO:0048935) | 2.50746996 |
88 | olfactory bulb development (GO:0021772) | 2.50335548 |
89 | axonal fasciculation (GO:0007413) | 2.50169410 |
90 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.49148392 |
91 | behavioral response to nicotine (GO:0035095) | 2.48767466 |
92 | lymphangiogenesis (GO:0001946) | 2.48757252 |
93 | glutamate secretion (GO:0014047) | 2.47900282 |
94 | cellular response to catecholamine stimulus (GO:0071870) | 2.47772375 |
95 | cellular response to monoamine stimulus (GO:0071868) | 2.47772375 |
96 | membrane assembly (GO:0071709) | 2.47568197 |
97 | otic vesicle formation (GO:0030916) | 2.47132615 |
98 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.47013784 |
99 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.46119702 |
100 | positive regulation of potassium ion transport (GO:0043268) | 2.46108761 |
101 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.44059181 |
102 | somite development (GO:0061053) | 2.43885169 |
103 | virion attachment to host cell (GO:0019062) | 2.43101509 |
104 | adhesion of symbiont to host cell (GO:0044650) | 2.43101509 |
105 | cilium organization (GO:0044782) | 2.42572212 |
106 | axoneme assembly (GO:0035082) | 2.42219467 |
107 | glycine transport (GO:0015816) | 2.41879627 |
108 | cilium assembly (GO:0042384) | 2.41121748 |
109 | peripheral nervous system development (GO:0007422) | 2.39290441 |
110 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.39015060 |
111 | inner ear receptor stereocilium organization (GO:0060122) | 2.38649719 |
112 | actin filament depolymerization (GO:0030042) | 2.37744562 |
113 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.37232457 |
114 | mitochondrion transport along microtubule (GO:0047497) | 2.37232457 |
115 | nucleobase catabolic process (GO:0046113) | 2.36487223 |
116 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.35112303 |
117 | amino acid import (GO:0043090) | 2.34553820 |
118 | membrane tubulation (GO:0097320) | 2.34278427 |
119 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.34138734 |
120 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.33842969 |
121 | negative chemotaxis (GO:0050919) | 2.32858084 |
122 | organelle transport along microtubule (GO:0072384) | 2.32780075 |
123 | regulation of timing of cell differentiation (GO:0048505) | 2.32713148 |
124 | regulation of extent of cell growth (GO:0061387) | 2.32241242 |
125 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.32026310 |
126 | response to epinephrine (GO:0071871) | 2.32013770 |
127 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.31945570 |
128 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.31199416 |
129 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.30966730 |
130 | urinary tract smooth muscle contraction (GO:0014848) | 2.29994653 |
131 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.29515558 |
132 | neuromuscular synaptic transmission (GO:0007274) | 2.29203015 |
133 | magnesium ion transport (GO:0015693) | 2.28193811 |
134 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.27572775 |
135 | outer ear morphogenesis (GO:0042473) | 2.27491277 |
136 | positive regulation of synapse assembly (GO:0051965) | 2.27314750 |
137 | protein localization to synapse (GO:0035418) | 2.27264624 |
138 | locomotory exploration behavior (GO:0035641) | 2.27088334 |
139 | smoothened signaling pathway (GO:0007224) | 2.26059103 |
140 | establishment of tissue polarity (GO:0007164) | 2.26049443 |
141 | establishment of planar polarity (GO:0001736) | 2.26049443 |
142 | axon development (GO:0061564) | 2.25970826 |
143 | response to monoamine (GO:0071867) | 2.25899339 |
144 | response to catecholamine (GO:0071869) | 2.25899339 |
145 | photoreceptor cell maintenance (GO:0045494) | 2.25676755 |
146 | muscle filament sliding (GO:0030049) | 2.24272984 |
147 | actin-myosin filament sliding (GO:0033275) | 2.24272984 |
148 | mating behavior (GO:0007617) | 2.23870114 |
149 | actin-mediated cell contraction (GO:0070252) | 2.23737391 |
150 | positive regulation of gastrulation (GO:2000543) | 2.22727272 |
151 | cellular component assembly involved in morphogenesis (GO:0010927) | 2.21876549 |
152 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.21840529 |
153 | regulation of cilium movement (GO:0003352) | 2.20333927 |
154 | short-term memory (GO:0007614) | 2.20271451 |
155 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.19555740 |
156 | hindbrain development (GO:0030902) | 2.17069416 |
157 | spinal cord development (GO:0021510) | 2.16773689 |
158 | cerebral cortex cell migration (GO:0021795) | 2.15494469 |
159 | regulation of development, heterochronic (GO:0040034) | 2.15146605 |
160 | regulation of synapse assembly (GO:0051963) | 2.14541376 |
161 | cardiac myofibril assembly (GO:0055003) | 2.14376587 |
162 | left/right pattern formation (GO:0060972) | 2.14334740 |
163 | cranial nerve morphogenesis (GO:0021602) | 2.14014340 |
164 | inner ear receptor cell development (GO:0060119) | 2.13276487 |
165 | notochord development (GO:0030903) | 2.09649139 |
166 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.08665930 |
167 | microtubule bundle formation (GO:0001578) | 2.07823661 |
168 | behavioral response to ethanol (GO:0048149) | 2.07396537 |
169 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.06210441 |
170 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.05889880 |
171 | auditory behavior (GO:0031223) | 2.05629467 |
172 | protein localization to cilium (GO:0061512) | 2.04945169 |
173 | protein heterotrimerization (GO:0070208) | 2.04639040 |
174 | renal tubule morphogenesis (GO:0061333) | 2.03007818 |
175 | axon extension (GO:0048675) | 2.02789710 |
176 | regulation of hippo signaling (GO:0035330) | 2.02752854 |
177 | retinal rod cell development (GO:0046548) | 2.02641020 |
178 | cell proliferation in forebrain (GO:0021846) | 2.01770268 |
179 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.01604524 |
180 | vocalization behavior (GO:0071625) | 2.01144386 |
181 | ephrin receptor signaling pathway (GO:0048013) | 2.00833862 |
182 | myoblast fusion (GO:0007520) | 1.98936481 |
183 | ganglion development (GO:0061548) | 1.98185337 |
184 | myofibril assembly (GO:0030239) | 1.96535836 |
185 | cerebral cortex development (GO:0021987) | 1.96510810 |
186 | establishment of nucleus localization (GO:0040023) | 1.95711517 |
187 | determination of left/right symmetry (GO:0007368) | 1.95352678 |
188 | embryonic body morphogenesis (GO:0010172) | 1.94580853 |
Rank | Gene Set | Z-score |
---|---|---|
1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.30618469 |
2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.11617215 |
3 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.06398042 |
4 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.99164232 |
5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.72672447 |
6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.68808601 |
7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.47426615 |
8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.38521327 |
9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.38521327 |
10 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.36777225 |
11 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.32214138 |
12 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.28979538 |
13 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.22098718 |
14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.19722176 |
15 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.18625061 |
16 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.17100797 |
17 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.15621942 |
18 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.12407630 |
19 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.12300088 |
20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.07258552 |
21 | * FUS_26573619_Chip-Seq_HEK293_Human | 2.01113195 |
22 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.97455434 |
23 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.94047343 |
24 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.93602674 |
25 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.90620431 |
26 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.84496512 |
27 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.82972051 |
28 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.82234173 |
29 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.69447452 |
30 | VDR_22108803_ChIP-Seq_LS180_Human | 1.67152946 |
31 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.65066830 |
32 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.59785200 |
33 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.58938000 |
34 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.58819427 |
35 | EWS_26573619_Chip-Seq_HEK293_Human | 1.57913062 |
36 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.56504188 |
37 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.55568755 |
38 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.52864858 |
39 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.52404431 |
40 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.42576900 |
41 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.42532543 |
42 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.42510925 |
43 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.40640596 |
44 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.38477944 |
45 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.37988586 |
46 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.37801966 |
47 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.37801966 |
48 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.36934984 |
49 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.36909986 |
50 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.36900237 |
51 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.36409659 |
52 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.36409659 |
53 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.35386319 |
54 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.33840023 |
55 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.33684409 |
56 | AR_25329375_ChIP-Seq_VCAP_Human | 1.33683192 |
57 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.33582883 |
58 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.33291274 |
59 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.32945596 |
60 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.31412180 |
61 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.30166430 |
62 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.29819739 |
63 | P300_19829295_ChIP-Seq_ESCs_Human | 1.29725792 |
64 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.29053590 |
65 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.28846514 |
66 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.28625539 |
67 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.28413383 |
68 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.24861556 |
69 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.24228073 |
70 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.22822509 |
71 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.22222723 |
72 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.21461868 |
73 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.21267853 |
74 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.20060778 |
75 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.19661270 |
76 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.19240136 |
77 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.18424534 |
78 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.18308501 |
79 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.18308501 |
80 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.18287502 |
81 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.17946098 |
82 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.16489648 |
83 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.15044095 |
84 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.14880396 |
85 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.14833643 |
86 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.14342827 |
87 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.13938761 |
88 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13060592 |
89 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.12935528 |
90 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.12860381 |
91 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.11042818 |
92 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.11013985 |
93 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.10916524 |
94 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.10768995 |
95 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.10663640 |
96 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.10365347 |
97 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.09970466 |
98 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.08589028 |
99 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.08544629 |
100 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.08097914 |
101 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.07744850 |
102 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.07114442 |
103 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.06544831 |
104 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05007681 |
105 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.03603143 |
106 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.03162841 |
107 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.02954115 |
108 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.01759119 |
109 | TCF4_23295773_ChIP-Seq_U87_Human | 1.01348149 |
110 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.97690474 |
111 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.97640811 |
112 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.97582496 |
113 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.97330177 |
114 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95493874 |
115 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95248262 |
116 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.95128267 |
117 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.95042330 |
118 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.94512598 |
119 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.94493673 |
120 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.92928361 |
121 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.92763859 |
122 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.92579848 |
123 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.91585672 |
124 | AR_19668381_ChIP-Seq_PC3_Human | 0.91134557 |
125 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.90948378 |
126 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.90827555 |
127 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.90290734 |
128 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.89199370 |
129 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.88573332 |
130 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.87042688 |
131 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.86872029 |
132 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.86804864 |
133 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.86496683 |
134 | TP53_16413492_ChIP-PET_HCT116_Human | 0.86158854 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004270_analgesia | 3.63092894 |
2 | MP0000920_abnormal_myelination | 3.32924366 |
3 | MP0003880_abnormal_central_pattern | 3.26882398 |
4 | MP0001968_abnormal_touch/_nociception | 3.03515913 |
5 | MP0002735_abnormal_chemical_nociception | 2.82910141 |
6 | MP0004859_abnormal_synaptic_plasticity | 2.70023486 |
7 | MP0002736_abnormal_nociception_after | 2.69532705 |
8 | MP0002734_abnormal_mechanical_nocicepti | 2.58263922 |
9 | MP0010030_abnormal_orbit_morphology | 2.54463774 |
10 | MP0002272_abnormal_nervous_system | 2.42701293 |
11 | MP0005171_absent_coat_pigmentation | 2.27361613 |
12 | MP0006292_abnormal_olfactory_placode | 2.21645590 |
13 | MP0003950_abnormal_plasma_membrane | 2.19892764 |
14 | MP0000778_abnormal_nervous_system | 2.18565491 |
15 | MP0002733_abnormal_thermal_nociception | 2.11796082 |
16 | MP0003635_abnormal_synaptic_transmissio | 2.00939088 |
17 | MP0001486_abnormal_startle_reflex | 1.98838567 |
18 | MP0001970_abnormal_pain_threshold | 1.96664578 |
19 | MP0002064_seizures | 1.93315170 |
20 | MP0004885_abnormal_endolymph | 1.87625180 |
21 | MP0003690_abnormal_glial_cell | 1.87515662 |
22 | MP0003329_amyloid_beta_deposits | 1.84019826 |
23 | MP0003634_abnormal_glial_cell | 1.81149579 |
24 | MP0000751_myopathy | 1.80833524 |
25 | MP0009745_abnormal_behavioral_response | 1.74509603 |
26 | MP0005423_abnormal_somatic_nervous | 1.73831920 |
27 | MP0005623_abnormal_meninges_morphology | 1.73795237 |
28 | MP0009046_muscle_twitch | 1.72477020 |
29 | MP0000049_abnormal_middle_ear | 1.69626284 |
30 | MP0004145_abnormal_muscle_electrophysio | 1.69459617 |
31 | MP0006276_abnormal_autonomic_nervous | 1.69223705 |
32 | MP0001299_abnormal_eye_distance/ | 1.66588169 |
33 | MP0004742_abnormal_vestibular_system | 1.64846627 |
34 | MP0004858_abnormal_nervous_system | 1.63404864 |
35 | MP0001529_abnormal_vocalization | 1.61314690 |
36 | MP0000749_muscle_degeneration | 1.59616988 |
37 | MP0002067_abnormal_sensory_capabilities | 1.59418970 |
38 | MP0008789_abnormal_olfactory_epithelium | 1.58495291 |
39 | MP0003937_abnormal_limbs/digits/tail_de | 1.58363749 |
40 | MP0008438_abnormal_cutaneous_collagen | 1.57411545 |
41 | MP0001905_abnormal_dopamine_level | 1.55956994 |
42 | MP0000955_abnormal_spinal_cord | 1.55707984 |
43 | MP0002234_abnormal_pharynx_morphology | 1.55213851 |
44 | MP0001485_abnormal_pinna_reflex | 1.52221683 |
45 | MP0004036_abnormal_muscle_relaxation | 1.51682315 |
46 | MP0002063_abnormal_learning/memory/cond | 1.49620358 |
47 | MP0004142_abnormal_muscle_tone | 1.48190378 |
48 | MP0002233_abnormal_nose_morphology | 1.44946487 |
49 | MP0002882_abnormal_neuron_morphology | 1.43183282 |
50 | MP0004133_heterotaxia | 1.42966379 |
51 | MP0002938_white_spotting | 1.40746609 |
52 | MP0002229_neurodegeneration | 1.38853336 |
53 | MP0002102_abnormal_ear_morphology | 1.38316715 |
54 | MP0000747_muscle_weakness | 1.38151143 |
55 | MP0002572_abnormal_emotion/affect_behav | 1.37808784 |
56 | MP0002184_abnormal_innervation | 1.37709681 |
57 | MP0004134_abnormal_chest_morphology | 1.36652483 |
58 | MP0001986_abnormal_taste_sensitivity | 1.36013408 |
59 | MP0006072_abnormal_retinal_apoptosis | 1.35043180 |
60 | MP0001293_anophthalmia | 1.32922552 |
61 | MP0001440_abnormal_grooming_behavior | 1.31233273 |
62 | MP0002837_dystrophic_cardiac_calcinosis | 1.30307342 |
63 | MP0000462_abnormal_digestive_system | 1.28459120 |
64 | MP0003632_abnormal_nervous_system | 1.27997841 |
65 | MP0003755_abnormal_palate_morphology | 1.26965676 |
66 | MP0005275_abnormal_skin_tensile | 1.26883820 |
67 | MP0005187_abnormal_penis_morphology | 1.25513236 |
68 | MP0005551_abnormal_eye_electrophysiolog | 1.24907755 |
69 | MP0005248_abnormal_Harderian_gland | 1.22879496 |
70 | MP0002653_abnormal_ependyma_morphology | 1.22243234 |
71 | MP0000566_synostosis | 1.21093961 |
72 | MP0000631_abnormal_neuroendocrine_gland | 1.20855474 |
73 | MP0005253_abnormal_eye_physiology | 1.20568207 |
74 | MP0003942_abnormal_urinary_system | 1.20159905 |
75 | MP0005394_taste/olfaction_phenotype | 1.16332180 |
76 | MP0005499_abnormal_olfactory_system | 1.16332180 |
77 | MP0003631_nervous_system_phenotype | 1.16273882 |
78 | MP0002752_abnormal_somatic_nervous | 1.16248310 |
79 | MP0000569_abnormal_digit_pigmentation | 1.16063520 |
80 | MP0002066_abnormal_motor_capabilities/c | 1.15081292 |
81 | MP0003137_abnormal_impulse_conducting | 1.14835764 |
82 | MP0004084_abnormal_cardiac_muscle | 1.14365246 |
83 | MP0003283_abnormal_digestive_organ | 1.14177614 |
84 | MP0010368_abnormal_lymphatic_system | 1.13777070 |
85 | MP0003633_abnormal_nervous_system | 1.13678022 |
86 | MP0003646_muscle_fatigue | 1.12638468 |
87 | MP0008569_lethality_at_weaning | 1.12464099 |
88 | MP0009384_cardiac_valve_regurgitation | 1.10737039 |
89 | MP0002697_abnormal_eye_size | 1.09518889 |
90 | MP0009780_abnormal_chondrocyte_physiolo | 1.09322939 |
91 | MP0004924_abnormal_behavior | 1.09005671 |
92 | MP0005386_behavior/neurological_phenoty | 1.09005671 |
93 | MP0005409_darkened_coat_color | 1.05323402 |
94 | MP0003119_abnormal_digestive_system | 1.04856501 |
95 | MP0002160_abnormal_reproductive_system | 1.03716398 |
96 | MP0001286_abnormal_eye_development | 1.03360572 |
97 | MP0003122_maternal_imprinting | 1.02004410 |
98 | MP0004085_abnormal_heartbeat | 1.01760664 |
99 | MP0003861_abnormal_nervous_system | 1.01122354 |
100 | MP0005503_abnormal_tendon_morphology | 1.00384382 |
101 | MP0003890_abnormal_embryonic-extraembry | 0.99836019 |
102 | MP0004811_abnormal_neuron_physiology | 0.99427229 |
103 | MP0002127_abnormal_cardiovascular_syste | 0.98885967 |
104 | MP0001984_abnormal_olfaction | 0.98014774 |
105 | MP0003935_abnormal_craniofacial_develop | 0.97770561 |
106 | MP0004272_abnormal_basement_membrane | 0.97555163 |
107 | MP0000428_abnormal_craniofacial_morphol | 0.97243508 |
108 | MP0008877_abnormal_DNA_methylation | 0.96266490 |
109 | MP0002108_abnormal_muscle_morphology | 0.95659167 |
110 | MP0003938_abnormal_ear_development | 0.95603407 |
111 | MP0005620_abnormal_muscle_contractility | 0.95527505 |
112 | MP0009053_abnormal_anal_canal | 0.95521593 |
113 | MP0001346_abnormal_lacrimal_gland | 0.95260059 |
114 | MP0004215_abnormal_myocardial_fiber | 0.94575376 |
115 | MP0003385_abnormal_body_wall | 0.93236560 |
116 | MP0010386_abnormal_urinary_bladder | 0.92138003 |
117 | MP0005391_vision/eye_phenotype | 0.92083661 |
118 | MP0003567_abnormal_fetal_cardiomyocyte | 0.91220951 |
119 | MP0002295_abnormal_pulmonary_circulatio | 0.90893556 |
120 | MP0002638_abnormal_pupillary_reflex | 0.89971812 |
121 | MP0004147_increased_porphyrin_level | 0.88879787 |
122 | MP0000427_abnormal_hair_cycle | 0.88760630 |
123 | MP0000013_abnormal_adipose_tissue | 0.86810173 |
124 | MP0002116_abnormal_craniofacial_bone | 0.86583597 |
125 | MP0001963_abnormal_hearing_physiology | 0.86500355 |
126 | MP0000026_abnormal_inner_ear | 0.85595489 |
127 | MP0002282_abnormal_trachea_morphology | 0.85537116 |
128 | MP0002972_abnormal_cardiac_muscle | 0.85291527 |
129 | MP0001177_atelectasis | 0.84981280 |
130 | MP0000762_abnormal_tongue_morphology | 0.83839680 |
131 | MP0000759_abnormal_skeletal_muscle | 0.82926045 |
132 | MP0003136_yellow_coat_color | 0.82656655 |
133 | MP0002557_abnormal_social/conspecific_i | 0.82621929 |
134 | MP0002751_abnormal_autonomic_nervous | 0.81241661 |
135 | MP0002152_abnormal_brain_morphology | 0.79051204 |
136 | MP0001958_emphysema | 0.78175145 |
137 | MP0000534_abnormal_ureter_morphology | 0.77429636 |
138 | MP0008260_abnormal_autophagy | 0.77084375 |
139 | MP0009250_abnormal_appendicular_skeleto | 0.76669186 |
140 | MP0000003_abnormal_adipose_tissue | 0.75877017 |
141 | MP0010678_abnormal_skin_adnexa | 0.75251404 |
142 | MP0005330_cardiomyopathy | 0.75018582 |
143 | MP0005410_abnormal_fertilization | 0.74072489 |
144 | MP0005369_muscle_phenotype | 0.73362478 |
145 | MP0004043_abnormal_pH_regulation | 0.72953952 |
146 | MP0005195_abnormal_posterior_eye | 0.72603850 |
147 | MP0004087_abnormal_muscle_fiber | 0.70360781 |
148 | MP0000372_irregular_coat_pigmentation | 0.70007023 |
149 | MP0002822_catalepsy | 0.69093207 |
150 | MP0000383_abnormal_hair_follicle | 0.68639748 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.77693917 |
2 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.77693917 |
3 | Neurofibrillary tangles (HP:0002185) | 4.11967361 |
4 | Abnormality of the corticospinal tract (HP:0002492) | 4.09630604 |
5 | Sensory axonal neuropathy (HP:0003390) | 3.96023268 |
6 | Insidious onset (HP:0003587) | 3.87527606 |
7 | Termporal pattern (HP:0011008) | 3.87527606 |
8 | Onion bulb formation (HP:0003383) | 3.84670958 |
9 | Supranuclear gaze palsy (HP:0000605) | 3.55771060 |
10 | Peripheral hypomyelination (HP:0007182) | 3.52325581 |
11 | Pheochromocytoma (HP:0002666) | 3.47333372 |
12 | Myokymia (HP:0002411) | 3.36046686 |
13 | Ankle clonus (HP:0011448) | 3.26918566 |
14 | Parakeratosis (HP:0001036) | 3.17379995 |
15 | Action tremor (HP:0002345) | 3.08841014 |
16 | Type 1 muscle fiber predominance (HP:0003803) | 3.07405415 |
17 | Spastic gait (HP:0002064) | 3.03869394 |
18 | Ulnar claw (HP:0001178) | 3.02765563 |
19 | Cerebral inclusion bodies (HP:0100314) | 3.01473693 |
20 | Hyporeflexia of lower limbs (HP:0002600) | 2.99755432 |
21 | Cerebral hypomyelination (HP:0006808) | 2.99389133 |
22 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.93073433 |
23 | Neuroendocrine neoplasm (HP:0100634) | 2.93027269 |
24 | Retinal dysplasia (HP:0007973) | 2.88653980 |
25 | Pancreatic fibrosis (HP:0100732) | 2.87552241 |
26 | Akinesia (HP:0002304) | 2.82735641 |
27 | Abnormality of midbrain morphology (HP:0002418) | 2.75970177 |
28 | Molar tooth sign on MRI (HP:0002419) | 2.75970177 |
29 | Muscle fiber splitting (HP:0003555) | 2.75876452 |
30 | Foot dorsiflexor weakness (HP:0009027) | 2.75175927 |
31 | Steppage gait (HP:0003376) | 2.73291288 |
32 | True hermaphroditism (HP:0010459) | 2.69746308 |
33 | Hammertoe (HP:0001765) | 2.67644218 |
34 | Pancreatic cysts (HP:0001737) | 2.67108464 |
35 | Aplasia involving bones of the extremities (HP:0009825) | 2.63944404 |
36 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.63944404 |
37 | Aplasia of the phalanges of the hand (HP:0009802) | 2.63944404 |
38 | Dysmetria (HP:0001310) | 2.62695388 |
39 | Medial flaring of the eyebrow (HP:0010747) | 2.62306187 |
40 | Alacrima (HP:0000522) | 2.60293850 |
41 | Nephronophthisis (HP:0000090) | 2.58065418 |
42 | Scanning speech (HP:0002168) | 2.56094244 |
43 | Atonic seizures (HP:0010819) | 2.55512685 |
44 | Intention tremor (HP:0002080) | 2.54236875 |
45 | Abnormality of the foot musculature (HP:0001436) | 2.51310977 |
46 | Occipital encephalocele (HP:0002085) | 2.47441100 |
47 | Lower limb muscle weakness (HP:0007340) | 2.42323309 |
48 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.40411781 |
49 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 2.39482173 |
50 | Gait imbalance (HP:0002141) | 2.38629394 |
51 | Focal seizures (HP:0007359) | 2.33835620 |
52 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.33506552 |
53 | Decreased motor nerve conduction velocity (HP:0003431) | 2.33083901 |
54 | Muscle fiber inclusion bodies (HP:0100299) | 2.32051004 |
55 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.31303014 |
56 | Focal motor seizures (HP:0011153) | 2.30332839 |
57 | Limb dystonia (HP:0002451) | 2.27876547 |
58 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.25303909 |
59 | Cerebral hemorrhage (HP:0001342) | 2.25245327 |
60 | Intestinal atresia (HP:0011100) | 2.24960373 |
61 | Congenital primary aphakia (HP:0007707) | 2.24584669 |
62 | Nemaline bodies (HP:0003798) | 2.24470492 |
63 | Difficulty running (HP:0009046) | 2.23202186 |
64 | Abnormal ciliary motility (HP:0012262) | 2.17275382 |
65 | Abnormal auditory evoked potentials (HP:0006958) | 2.16912130 |
66 | Chronic hepatic failure (HP:0100626) | 2.14661500 |
67 | Slow saccadic eye movements (HP:0000514) | 2.14632903 |
68 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.13780736 |
69 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.13780736 |
70 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.11943005 |
71 | Abnormality of the renal medulla (HP:0100957) | 2.11290829 |
72 | Distal sensory impairment (HP:0002936) | 2.10597075 |
73 | Abnormality of glycolysis (HP:0004366) | 2.09683269 |
74 | Increased serum pyruvate (HP:0003542) | 2.09683269 |
75 | Optic nerve hypoplasia (HP:0000609) | 2.08773808 |
76 | Cystic liver disease (HP:0006706) | 2.07461610 |
77 | Postaxial hand polydactyly (HP:0001162) | 2.05538082 |
78 | Autoamputation (HP:0001218) | 2.04442889 |
79 | Exercise-induced muscle cramps (HP:0003710) | 2.04103313 |
80 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.03898412 |
81 | Septo-optic dysplasia (HP:0100842) | 2.03501020 |
82 | Supernumerary spleens (HP:0009799) | 2.03289004 |
83 | Stridor (HP:0010307) | 2.03041180 |
84 | Abnormality of the labia minora (HP:0012880) | 2.02776811 |
85 | Broad metatarsal (HP:0001783) | 2.01698647 |
86 | Decreased lacrimation (HP:0000633) | 2.01660577 |
87 | Hyperventilation (HP:0002883) | 2.00316522 |
88 | Hypoplasia of the iris (HP:0007676) | 1.99884115 |
89 | Cutaneous finger syndactyly (HP:0010554) | 1.99447191 |
90 | Broad-based gait (HP:0002136) | 1.99323856 |
91 | Bifid tongue (HP:0010297) | 1.97033971 |
92 | Nephrogenic diabetes insipidus (HP:0009806) | 1.96574978 |
93 | Coronal craniosynostosis (HP:0004440) | 1.96290097 |
94 | Calf muscle hypertrophy (HP:0008981) | 1.96090068 |
95 | Megalencephaly (HP:0001355) | 1.95479833 |
96 | Wrist flexion contracture (HP:0001239) | 1.95158832 |
97 | Rhinitis (HP:0012384) | 1.94356704 |
98 | Rimmed vacuoles (HP:0003805) | 1.94199975 |
99 | Urinary urgency (HP:0000012) | 1.94067250 |
100 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.93747062 |
101 | Scapular winging (HP:0003691) | 1.93633185 |
102 | Preaxial foot polydactyly (HP:0001841) | 1.90957580 |
103 | EMG: myopathic abnormalities (HP:0003458) | 1.90438896 |
104 | Leukodystrophy (HP:0002415) | 1.89676837 |
105 | Anencephaly (HP:0002323) | 1.88287335 |
106 | Hypomagnesemia (HP:0002917) | 1.88279511 |
107 | Postaxial foot polydactyly (HP:0001830) | 1.88019915 |
108 | Prolonged QT interval (HP:0001657) | 1.87451970 |
109 | Poor speech (HP:0002465) | 1.86223621 |
110 | Sclerocornea (HP:0000647) | 1.86120506 |
111 | Abnormality of the calf musculature (HP:0001430) | 1.85657730 |
112 | Absent septum pellucidum (HP:0001331) | 1.84683295 |
113 | Type II lissencephaly (HP:0007260) | 1.84573799 |
114 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.83647439 |
115 | Deformed tarsal bones (HP:0008119) | 1.83516034 |
116 | Progressive cerebellar ataxia (HP:0002073) | 1.83038801 |
117 | Vaginal atresia (HP:0000148) | 1.81552097 |
118 | Myotonia (HP:0002486) | 1.80949813 |
119 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.79869967 |
120 | Hypoplasia of the brainstem (HP:0002365) | 1.79869967 |
121 | Hypoplastic pelvis (HP:0008839) | 1.79635113 |
122 | Colon cancer (HP:0003003) | 1.79025229 |
123 | Clonus (HP:0002169) | 1.78799730 |
124 | Increased circulating renin level (HP:0000848) | 1.78025900 |
125 | Genital tract atresia (HP:0001827) | 1.77444335 |
126 | Abdominal situs inversus (HP:0003363) | 1.76680495 |
127 | Abnormality of abdominal situs (HP:0011620) | 1.76680495 |
128 | Cutaneous syndactyly (HP:0012725) | 1.76254387 |
129 | Gowers sign (HP:0003391) | 1.75094966 |
130 | Tubulointerstitial nephritis (HP:0001970) | 1.74858624 |
131 | Epileptic encephalopathy (HP:0200134) | 1.74749592 |
132 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.74627418 |
133 | Absent/shortened dynein arms (HP:0200106) | 1.74627418 |
134 | Calcaneovalgus deformity (HP:0001848) | 1.74050300 |
135 | Broad foot (HP:0001769) | 1.73667758 |
136 | Premature rupture of membranes (HP:0001788) | 1.73384704 |
137 | Thickened helices (HP:0000391) | 1.72781406 |
138 | Increased variability in muscle fiber diameter (HP:0003557) | 1.72731242 |
139 | Anteriorly placed anus (HP:0001545) | 1.72685220 |
140 | Drooling (HP:0002307) | 1.72561490 |
141 | Bell-shaped thorax (HP:0001591) | 1.72117722 |
142 | Distal arthrogryposis (HP:0005684) | 1.72115083 |
143 | Aqueductal stenosis (HP:0002410) | 1.71958435 |
144 | Hip contracture (HP:0003273) | 1.71936737 |
145 | Renal hypoplasia (HP:0000089) | 1.71098344 |
146 | Abnormality of dentin (HP:0010299) | 1.71060235 |
147 | Slender build (HP:0001533) | 1.71050213 |
148 | Ankle contracture (HP:0006466) | 1.70937072 |
149 | Buphthalmos (HP:0000557) | 1.70633795 |
150 | Narrow forehead (HP:0000341) | 1.70395318 |
151 | Limited hip movement (HP:0008800) | 1.70358970 |
152 | Bradycardia (HP:0001662) | 1.69719844 |
153 | Premature skin wrinkling (HP:0100678) | 1.67808825 |
154 | Chin dimple (HP:0010751) | 1.67175825 |
155 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.66989475 |
156 | Short 4th metacarpal (HP:0010044) | 1.66989475 |
157 | Absent speech (HP:0001344) | 1.66614355 |
158 | Central scotoma (HP:0000603) | 1.66544756 |
159 | Spinal rigidity (HP:0003306) | 1.65428198 |
160 | Soft skin (HP:0000977) | 1.64693396 |
161 | CNS hypomyelination (HP:0003429) | 1.64314251 |
162 | Follicular hyperkeratosis (HP:0007502) | 1.63973493 |
163 | Postural tremor (HP:0002174) | 1.63712330 |
164 | Limb-girdle muscle weakness (HP:0003325) | 1.63519438 |
165 | Exercise-induced myalgia (HP:0003738) | 1.62827296 |
166 | Abnormality of the ischium (HP:0003174) | 1.62788972 |
167 | Sudden death (HP:0001699) | 1.62354278 |
168 | Anophthalmia (HP:0000528) | 1.61933955 |
169 | Abnormality of the parathyroid morphology (HP:0011766) | 1.60414219 |
170 | Increased corneal curvature (HP:0100692) | 1.59818163 |
171 | Tubular atrophy (HP:0000092) | 1.58638900 |
172 | Poor coordination (HP:0002370) | 1.58150332 |
173 | Preaxial hand polydactyly (HP:0001177) | 1.57445372 |
174 | Short foot (HP:0001773) | 1.57159679 |
175 | High anterior hairline (HP:0009890) | 1.56597663 |
176 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.56576954 |
177 | Intellectual disability, moderate (HP:0002342) | 1.55855059 |
178 | Congenital hepatic fibrosis (HP:0002612) | 1.53157289 |
179 | Abnormality of the antihelix (HP:0009738) | 1.52985746 |
180 | Cerebellar dysplasia (HP:0007033) | 1.52039433 |
181 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.51375316 |
182 | Round ear (HP:0100830) | 1.49613618 |
183 | Infantile muscular hypotonia (HP:0008947) | 1.48396357 |
184 | Pachygyria (HP:0001302) | 1.46495688 |
185 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.46234636 |
186 | Fibular hypoplasia (HP:0003038) | 1.44142080 |
187 | Proximal amyotrophy (HP:0007126) | 1.43463901 |
Rank | Gene Set | Z-score |
---|---|---|
1 | STK39 | 5.34605998 |
2 | OXSR1 | 3.42374635 |
3 | EPHB1 | 3.10839677 |
4 | NTRK1 | 2.75486639 |
5 | TNIK | 2.70969649 |
6 | LIMK1 | 2.45547666 |
7 | WNK3 | 2.44058056 |
8 | BCR | 2.36926406 |
9 | WNK4 | 2.33538849 |
10 | PKN1 | 2.18757382 |
11 | FRK | 2.17131406 |
12 | PHKG2 | 1.94927883 |
13 | PHKG1 | 1.94927883 |
14 | MET | 1.90381647 |
15 | PAK6 | 1.87090605 |
16 | FGFR2 | 1.86680696 |
17 | UHMK1 | 1.84459941 |
18 | WNK1 | 1.84251456 |
19 | GRK1 | 1.69795817 |
20 | MARK1 | 1.67817882 |
21 | PAK3 | 1.57159543 |
22 | NTRK3 | 1.52601684 |
23 | ROCK2 | 1.51853255 |
24 | NEK6 | 1.50743354 |
25 | MAP4K2 | 1.50189185 |
26 | MAPKAPK5 | 1.49780874 |
27 | CDK19 | 1.49191933 |
28 | NUAK1 | 1.48719491 |
29 | SGK494 | 1.42219791 |
30 | SGK223 | 1.42219791 |
31 | STK38L | 1.41132387 |
32 | CAMK2D | 1.40931152 |
33 | TRIM28 | 1.39409375 |
34 | CAMK2B | 1.32842338 |
35 | ERBB3 | 1.28681755 |
36 | CSNK1A1L | 1.24710522 |
37 | MINK1 | 1.24394973 |
38 | CSNK1G3 | 1.23684875 |
39 | KSR2 | 1.22025370 |
40 | LATS1 | 1.20958452 |
41 | MAPK13 | 1.20191516 |
42 | MKNK2 | 1.19306673 |
43 | ICK | 1.18549202 |
44 | MAPK15 | 1.17900130 |
45 | LMTK2 | 1.15986029 |
46 | EPHA4 | 1.15738462 |
47 | MAP3K2 | 1.13615425 |
48 | CSNK1G2 | 1.12241588 |
49 | AKT3 | 1.11858859 |
50 | ADRBK2 | 1.11356783 |
51 | CCNB1 | 1.11299731 |
52 | CASK | 1.10556758 |
53 | PRPF4B | 1.07926149 |
54 | CDK5 | 1.05432534 |
55 | TYRO3 | 1.05016360 |
56 | PNCK | 1.03396197 |
57 | CAMK2G | 0.97616569 |
58 | CAMK2A | 0.95981466 |
59 | CDK14 | 0.95692062 |
60 | MAP3K9 | 0.95363456 |
61 | NEK1 | 0.95327569 |
62 | PRKCE | 0.92644979 |
63 | DYRK2 | 0.91332213 |
64 | PRKD1 | 0.87622671 |
65 | TTN | 0.87330773 |
66 | CSNK1G1 | 0.86815515 |
67 | MKNK1 | 0.86513323 |
68 | DMPK | 0.85594213 |
69 | ROCK1 | 0.84945709 |
70 | RET | 0.84803349 |
71 | DDR2 | 0.84769536 |
72 | MAP3K4 | 0.83804135 |
73 | PBK | 0.81582102 |
74 | PRKD3 | 0.80403466 |
75 | OBSCN | 0.79222879 |
76 | MARK2 | 0.78508987 |
77 | IRAK2 | 0.78325712 |
78 | PLK3 | 0.75938491 |
79 | CDK15 | 0.73500732 |
80 | PTK2B | 0.73411270 |
81 | CDK18 | 0.72725561 |
82 | FGR | 0.72663671 |
83 | DYRK3 | 0.71365805 |
84 | PIK3CA | 0.71234263 |
85 | FER | 0.70428126 |
86 | PLK4 | 0.69652582 |
87 | EPHB2 | 0.68863416 |
88 | GRK5 | 0.68591620 |
89 | ADRBK1 | 0.67504374 |
90 | VRK1 | 0.65841398 |
91 | PLK2 | 0.65548686 |
92 | TGFBR1 | 0.65387770 |
93 | INSRR | 0.65148835 |
94 | PDPK1 | 0.64954539 |
95 | DYRK1A | 0.64915792 |
96 | MUSK | 0.64527442 |
97 | TIE1 | 0.62692657 |
98 | CDK11A | 0.62333747 |
99 | LATS2 | 0.60454047 |
100 | ZAK | 0.59341243 |
101 | BRSK2 | 0.56328558 |
102 | KSR1 | 0.55809453 |
103 | FYN | 0.55492318 |
104 | PDGFRB | 0.54367962 |
105 | EPHA3 | 0.54009523 |
106 | PRKCH | 0.53731082 |
107 | ARAF | 0.53673506 |
108 | PDGFRA | 0.53666251 |
109 | NEK2 | 0.53440290 |
110 | PTK2 | 0.52644680 |
111 | WEE1 | 0.52413445 |
112 | SRPK1 | 0.51889875 |
113 | MYLK | 0.51533292 |
114 | NTRK2 | 0.51134094 |
115 | TTK | 0.49594988 |
116 | STK3 | 0.49438494 |
117 | PRKCQ | 0.49073911 |
118 | ERBB4 | 0.48029501 |
119 | PLK1 | 0.47866731 |
120 | FGFR1 | 0.47701658 |
121 | PRKG1 | 0.47303677 |
122 | CAMK1 | 0.46246751 |
123 | MAP2K7 | 0.45912924 |
124 | MAP3K7 | 0.45535983 |
125 | CDC42BPA | 0.45332570 |
126 | PINK1 | 0.44362978 |
127 | PRKCG | 0.43554800 |
128 | CAMK1G | 0.43414122 |
129 | DYRK1B | 0.42569719 |
130 | PRKACB | 0.42137938 |
131 | TSSK6 | 0.41722672 |
132 | PRKAA1 | 0.40600336 |
133 | BMPR1B | 0.40455968 |
134 | TESK2 | 0.39271230 |
135 | PRKD2 | 0.39080659 |
136 | CAMKK2 | 0.37787700 |
137 | PRKACA | 0.37272935 |
138 | DAPK2 | 0.37087854 |
139 | TRPM7 | 0.37081557 |
140 | IRAK1 | 0.35905591 |
141 | PDK2 | 0.35105114 |
142 | PDK1 | 0.34252052 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 4.04875100 |
2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.10588537 |
3 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.68642543 |
4 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.58461514 |
5 | Axon guidance_Homo sapiens_hsa04360 | 2.14985923 |
6 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.86858164 |
7 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.85097778 |
8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.74371060 |
9 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.73483743 |
10 | GABAergic synapse_Homo sapiens_hsa04727 | 1.65754020 |
11 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.62611553 |
12 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.59331243 |
13 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.55043696 |
14 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.53986057 |
15 | Circadian entrainment_Homo sapiens_hsa04713 | 1.52589148 |
16 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.48601653 |
17 | Morphine addiction_Homo sapiens_hsa05032 | 1.47139520 |
18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.45865926 |
19 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.39777904 |
20 | Circadian rhythm_Homo sapiens_hsa04710 | 1.38761684 |
21 | Phototransduction_Homo sapiens_hsa04744 | 1.35921978 |
22 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.34769039 |
23 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.33179036 |
24 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.30056633 |
25 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.28348165 |
26 | Olfactory transduction_Homo sapiens_hsa04740 | 1.28228398 |
27 | Long-term depression_Homo sapiens_hsa04730 | 1.27711660 |
28 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.27338915 |
29 | Salivary secretion_Homo sapiens_hsa04970 | 1.27133301 |
30 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.26145091 |
31 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.25496336 |
32 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.23568495 |
33 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.23106248 |
34 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.22623358 |
35 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.22560572 |
36 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.21682179 |
37 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.18810448 |
38 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.18112640 |
39 | Tight junction_Homo sapiens_hsa04530 | 1.17934320 |
40 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.17609973 |
41 | Insulin secretion_Homo sapiens_hsa04911 | 1.17219868 |
42 | Taste transduction_Homo sapiens_hsa04742 | 1.17111247 |
43 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.16038328 |
44 | Basal transcription factors_Homo sapiens_hsa03022 | 1.15401560 |
45 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.13000737 |
46 | Gap junction_Homo sapiens_hsa04540 | 1.12918555 |
47 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.11061715 |
48 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.10686855 |
49 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.09996890 |
50 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.09903054 |
51 | Nicotine addiction_Homo sapiens_hsa05033 | 1.09147644 |
52 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.09023646 |
53 | Cocaine addiction_Homo sapiens_hsa05030 | 1.04599532 |
54 | Alzheimers disease_Homo sapiens_hsa05010 | 1.04345183 |
55 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.03728739 |
56 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.03686035 |
57 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.03254438 |
58 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.03064791 |
59 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.02917546 |
60 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.00913060 |
61 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.00842610 |
62 | Long-term potentiation_Homo sapiens_hsa04720 | 1.00720271 |
63 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.00706131 |
64 | Renin secretion_Homo sapiens_hsa04924 | 1.00087135 |
65 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.98224026 |
66 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.98011148 |
67 | Parkinsons disease_Homo sapiens_hsa05012 | 0.95001203 |
68 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.93314768 |
69 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.92087408 |
70 | Adherens junction_Homo sapiens_hsa04520 | 0.91140118 |
71 | Endocytosis_Homo sapiens_hsa04144 | 0.89569269 |
72 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.89376976 |
73 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.88618549 |
74 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.87531115 |
75 | Huntingtons disease_Homo sapiens_hsa05016 | 0.87233258 |
76 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.86963084 |
77 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.86944336 |
78 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.85100472 |
79 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.84678687 |
80 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.82966598 |
81 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.78671448 |
82 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.78665147 |
83 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.78542452 |
84 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.77481464 |
85 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.76898929 |
86 | Homologous recombination_Homo sapiens_hsa03440 | 0.75844577 |
87 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.75355444 |
88 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.75003946 |
89 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.74760775 |
90 | Melanoma_Homo sapiens_hsa05218 | 0.74568092 |
91 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.74561737 |
92 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.74389964 |
93 | Melanogenesis_Homo sapiens_hsa04916 | 0.73951651 |
94 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.73509386 |
95 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.73311304 |
96 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.73197351 |
97 | Focal adhesion_Homo sapiens_hsa04510 | 0.70935787 |
98 | Lysine degradation_Homo sapiens_hsa00310 | 0.70654177 |
99 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.69069100 |
100 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.64714317 |
101 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.63291639 |
102 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.62990686 |
103 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.62177245 |
104 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.61693185 |
105 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.61266896 |
106 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.59936165 |
107 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.58190756 |
108 | Phagosome_Homo sapiens_hsa04145 | 0.57453866 |
109 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.55904511 |
110 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.55839374 |
111 | Protein export_Homo sapiens_hsa03060 | 0.54405141 |
112 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.53930527 |
113 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.53902341 |
114 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.53886554 |
115 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.53824795 |
116 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.53436189 |
117 | Mineral absorption_Homo sapiens_hsa04978 | 0.53207389 |
118 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.52487728 |
119 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.52475153 |
120 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.51962856 |
121 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.51898626 |
122 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.51542889 |
123 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.50327922 |
124 | Purine metabolism_Homo sapiens_hsa00230 | 0.49845810 |
125 | Glioma_Homo sapiens_hsa05214 | 0.47483741 |
126 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.46723543 |
127 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.46642387 |
128 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.46349786 |
129 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.44771728 |
130 | RNA degradation_Homo sapiens_hsa03018 | 0.44680347 |
131 | Salmonella infection_Homo sapiens_hsa05132 | 0.43769504 |
132 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.43610832 |
133 | Histidine metabolism_Homo sapiens_hsa00340 | 0.43019448 |
134 | Alcoholism_Homo sapiens_hsa05034 | 0.38904187 |
135 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.38897357 |
136 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.38838346 |
137 | RNA polymerase_Homo sapiens_hsa03020 | 0.38557561 |